发明名称 HUMANIZED c-Kit ANTIBODY
摘要 <P>PROBLEM TO BE SOLVED: To provide compositions for treating c-Kit associated inflammatory, fibrotic, autoimmune and cancerous diseases, and to provide compositions containing humanized c-Kit antibodies. <P>SOLUTION: This invention relates to compositions and methods for treating c-Kit associated disorders such as fibrosis, and more particularly, to compositions containing humanized c-Kit antibodies. The invention provides agents that are antagonists and neutral antagonists of SCF at the cell-associated and membrane c-Kit receptor, such as monoclonal antibodies. Humanized (non-murine) monoclonal antibodies that bind c-Kit are provided. The invention also provides nucleic acid sequence encoding any of the antibodies or specific binding agents. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012126746(A) 申请公布日期 2012.07.05
申请号 JP20120077479 申请日期 2012.03.29
申请人 AMGEN INC 发明人 NG GORDON;SHEN WENYAN
分类号 C07K16/28;A61K39/395;A61K45/00;A61P1/08;A61P1/12;A61P1/16;A61P7/00;A61P9/00;A61P11/00;A61P13/12;A61P17/00;A61P17/02;A61P19/10;A61P25/00;A61P25/06;A61P27/00;A61P27/06;A61P27/12;A61P29/00;A61P31/16;A61P31/20;A61P35/00;A61P35/02;A61P37/00;A61P37/06;A61P37/08;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12P21/08 主分类号 C07K16/28
代理机构 代理人
主权项
地址